Literature DB >> 12037099

Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

James R Johnson1, Catherine Jerome, Daniel R Boster, Ann E Stapleton, Phillip I Tarr.   

Abstract

The frequency of Shiga toxin (Stx)-producing Escherichia coli (STEC) in the urinary tract, which can precipitate the hemolytic-uremic syndrome, is unknown. We tested 597 urinary E. coli isolates by Stx immunoassay and found no STEC. The routine screening of urinary E. coli for the ability to produce Stx is not warranted.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12037099      PMCID： PMC130820          DOI： 10.1128/JCM.40.6.2247-2248.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy.

Authors:  M Miedouge; J Hacini; F Grimont; J Watine
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

2.  The low prevalence of shiga-toxin production among sorbitol non-fermenting Escherichia coli urinary tract isolates does not warrant routine screening.

Authors:  D Wilson; M Tuohy; G W Procop
Journal:  Clin Infect Dis       Date:  2000-11       Impact factor: 9.079

3.  Testing of urinary Escherichia coli isolates for Shiga toxin production.

Authors:  C M Thorpe; D W Acheson
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

Authors:  C S Wong; S Jelacic; R L Habeeb; S L Watkins; P I Tarr
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

5.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

6.  Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis.

Authors:  J R Johnson; T T O'Bryan; P Delavari; M Kuskowski; A Stapleton; U Carlino; T A Russo
Journal:  J Infect Dis       Date:  2001-04-13       Impact factor: 5.226

7.  Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure.

Authors:  P I Tarr; S S Bilge; J C Vary; S Jelacic; R L Habeeb; T R Ward; M R Baylor; T E Besser
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli.

Authors:  F Scheutz; B Olesen; A Nørgaard
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

9.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.

Authors:  H L Mobley; D M Green; A L Trifillis; D E Johnson; G R Chippendale; C V Lockatell; B D Jones; J W Warren
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis.

Authors:  J R Johnson; T A Russo; P I Tarr; U Carlino; S S Bilge; J C Vary; A L Stell
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441
View more
  3 in total

1.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Authors:  Dejan Lavrek; Sebastiano A G Lava; Gregorio P Milani; Giacomo D Simonetti; Mario G Bianchetti; Olivier Giannini
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

3.  Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6.

Authors:  Martina Bielaszewska; Roswitha Schiller; Lydia Lammers; Andreas Bauwens; Angelika Fruth; Barbara Middendorf; M Alexander Schmidt; Phillip I Tarr; Ulrich Dobrindt; Helge Karch; Alexander Mellmann
Journal:  EMBO Mol Med       Date:  2014-01-10       Impact factor: 12.137
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.